Neuromuscular junction maturation defects precede impaired lower motor neuron connectivity in Charcot-Marie-Tooth Type 2D mice

Human Molecular Genetics

Volumn 23, Issue 10, 2014, Pages 2639-2650

  Sleigh, James N ^a,b,c,d   Grice, Stuart J ^c   Burgess, Robert W ^d   Talbot, Kevin ^a,c   Cader, M Zameel ^a,b,c  

^a UNIVERSITY OF OXFORD   (United Kingdom)

^b UNIVERSITY OF OXFORD   (United Kingdom)

^c UNIVERSITY OF OXFORD   (United Kingdom)

^d JACKSON LABORATORY   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

ABDOMINAL WALL; ABDOMINAL WALL MUSCULATURE; ANIMAL CELL; ANIMAL EXPERIMENT; ANIMAL MODEL; ANIMAL TISSUE; ARTICLE; CHARCOT MARIE TOOTH TYPE 2D; CONTROLLED STUDY; DENERVATION; DEVELOPMENTAL DISORDER; DISEASE SEVERITY; DOWN REGULATION; HEREDITARY MOTOR SENSORY NEUROPATHY; MOTONEURON; MOTOR NEURON DISEASE; MOUSE; NEUROMUSCULAR JUNCTION DISORDER; NEUROMUSCULAR SYNAPSE; NONHUMAN; PHENOTYPE; PRIORITY JOURNAL; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; SYNAPSE VESICLE; UPREGULATION; ANIMAL; C57BL MOUSE; GENETICS; HINDLIMB; INNERVATION; MISSENSE MUTATION; PATHOLOGY; TRANSGENIC MOUSE;

GLYCINE TRANSFER RNA LIGASE;

ABDOMINAL MUSCLES; ANIMALS; CHARCOT-MARIE-TOOTH DISEASE; GLYCINE-TRNA LIGASE; HINDLIMB; MICE, INBRED C57BL; MICE, TRANSGENIC; MOTOR NEURONS; MUTATION, MISSENSE; NEUROMUSCULAR JUNCTION;

EID: 84896133061     PISSN: 09646906     EISSN: 14602083     Source Type: Journal    
DOI: 10.1093/hmg/ddt659     Document Type: Article

References (68)

1. Skre, H. (1974) Genetic and clinical aspects of Charcot-Marie-Tooth's disease. Clin. Genet., 6, 98-118.
2. Reilly, M.M., Murphy, S.M. and Laura, M. (2011) Charcot-Marie-Tooth disease. J. Peripher. Nerv. Syst., 16, 1-14.
3. Ibba, M. and Soll, D. (2000) Aminoacyl-tRNA synthesis. Annu. Rev. Biochem., 69, 617-650.
4. Antonellis, A. and Green, E.D. (2008) The role of aminoacyl-tRNA synthetases in genetic diseases. Annu. Rev. Genom. Hum. Genet., 9, 87-107.
5. Antonellis, A., Ellsworth, R.E., Sambuughin, N., Puls, I., Abel, A., Lee-Lin, S.Q., Jordanova, A., Kremensky, I., Christodoulou, K., Middleton, L.T. et al. (2003) Glycyl tRNA synthetase mutations in Charcot-Marie-Tooth disease type 2D and distal spinal muscular atrophy type V. Am. J. Hum. Genet., 72, 1293-1299.
6. Sivakumar, K., Kyriakides, T., Puls, I., Nicholson, G.A., Funalot, B., Antonellis, A., Sambuughin, N., Christodoulou, K., Beggs, J.L., Zamba-Papanicolaou, E. et al. (2005) Phenotypic spectrum of disorders associated with glycyl-tRNAsynthetase mutations. Brain, 128, 2304-2314.
7. Dubourg, O., Azzedine, H., Yaou, R.B., Pouget, J., Barois, A., Meininger, V., Bouteiller, D., Ruberg, M., Brice, A. and LeGuern, E. (2006) The G526R glycyl-tRNA synthetase gene mutation in distal hereditary motor neuropathy type V. Neurology, 66, 1721-1726.
8. Del Bo, R., Locatelli, F., Corti, S., Scarlato, M., Ghezzi, S., Prelle, A., Fagiolari, G., Moggio, M., Carpo, M., Bresolin, N. et al. (2006) Coexistence of CMT-2D and distal SMA-V phenotypes in an Italian family with a GARS gene mutation. Neurology, 66, 752-754.
9. James, P.A., Cader, M.Z., Muntoni, F., Childs, A.M., Crow, Y.J. and Talbot, K. (2006) Severe childhoodSMAand axonalCMTdue to anticodon binding domain mutations in the GARS gene. Neurology, 67, 1710-1712.
10. Eskuri, J.M., Stanley, C.M., Moore, S.A. and Mathews, K.D. (2012) Infantile onset CMT2D/dSMA V in monozygotic twins due to a mutation in the anticodon-binding domain of GARS. J. Peripher. Nerv. Syst., 17, 132-134.
11. Chang, K.J. and Wang, C.C. (2004) Translation initiation from a naturally occurring non-AUG codon in Saccharomyces cerevisiae. J. Biol. Chem., 279, 13778-13785.
12. Chihara, T., Luginbuhl, D. and Luo, L. (2007) Cytoplasmic and mitochondrial protein translation in axonal and dendritic terminal arborization. Nat. Neurosci., 10, 828-837.
13. Mudge, S.J., Williams, J.H., Eyre, H.J., Sutherland, G.R., Cowan, P.J. and Power, D.A. (1998)Complex organisation of the 5'-end of thehumanglycine tRNA synthetase gene. Gene, 209, 45-50.
14. Turner, R.J., Lovato, M.andSchimmel, P. (2000)Oneof two genes encoding glycyl-tRNA synthetase in Saccharomyces cerevisiae provides mitochondrial and cytoplasmic functions. J. Biol. Chem., 275, 27681-27688.
15. He, W., Zhang, H.M., Chong, Y.E., Guo, M., Marshall, A.G. and Yang, X.L. (2011) Dispersed disease-causing neomorphic mutations on a single protein promote the same localized conformational opening. Proc. Natl. Acad. Sci. U S A, 108, 12307-12312.
16. Motley, W.W., Talbot, K. and Fischbeck, K.H. (2010) GARS axonopathy: not every neuron's cup of tRNA. Trends Neurosci., 33, 59-66.
17. Park, M.C., Kang, T., Jin, D., Han, J.M., Kim, S.B., Park, Y.J., Cho, K., Park, Y.W., Guo, M., He, W. et al. (2012) Secretedhumanglycyl-tRNAsynthetase implicated in defense against ERK-activated tumorigenesis. Proc. Natl. Acad. Sci. U S A, 109, E640-E647.
18. Nangle, L.A., Zhang, W., Xie, W., Yang, X.L. and Schimmel, P. (2007) Charcot-Marie-Tooth disease-associated mutant tRNA synthetases linked to altered dimer interface and neurite distribution defect. Proc. Natl. Acad. Sci. U S A, 104, 11239-11244.
19. Seburn, K.L., Nangle, L.A., Cox, G.A., Schimmel, P. and Burgess, R.W. (2006) An active dominant mutation of glycyl-tRNA synthetase causes neuropathy in a Charcot-Marie-Tooth2D mouse model. Neuron, 51, 715-726.
20. Achilli, F., Bros-Facer, V., Williams, H.P., Banks, G.T., AlQatari, M., Chia, R., Tucci, V., Groves, M., Nickols, C.D., Seburn, K.L. et al. (2009) An ENU-induced mutation in mouse glycyl-tRNA synthetase (GARS) causes peripheral sensory and motor phenotypes creating a model of Charcot-Marie-Tooth type 2D peripheral neuropathy. Dis. Model. Mech., 2, 359-373.
21. Xie, W., Nangle, L.A., Zhang, W., Schimmel, P. and Yang, X.L. (2007) Long-range structural effects of a Charcot-Marie-Tooth disease-causing mutation in human glycyl-tRNA synthetase. Proc. Natl. Acad. Sci. U S A, 104, 9976-9981.
22. Motley, W.W., Seburn, K.L., Nawaz, M.H., Miers, K.E., Cheng, J., Antonellis, A., Green, E.D., Talbot, K., Yang, X.L., Fischbeck, K.H. et al. (2011) Charcot-Marie-Tooth-linked mutant GARS is toxic to peripheral neurons independent of wild-type GARS levels. PLoS Genet., 7, e1002399.
23. Murray, L.M., Talbot, K. and Gillingwater, T.H. (2010) Neuromuscular synaptic vulnerability in motor neurone disease: amyotrophic lateral sclerosis and spinal muscular atrophy. Neuropathol. Appl. Neurobiol., 36, 133-156.
24. d'Ydewalle, C., Krishnan, J., Chiheb, D.M., Van Damme, P., Irobi, J., Kozikowski, A.P., Vanden Berghe, P., Timmerman, V., Robberecht, W. and Van Den Bosch, L. (2011) HDAC6 inhibitors reverse axonal loss in a mouse model of mutant HSPB1-induced Charcot-Marie-Tooth disease. Nat. Med., 17, 968-974.
25. Patzkó, A., Bai, Y., Saporta, M.A., Katona, I., Wu, X., Vizzuso, D., Feltri, M.L., Wang, S., Dillon, L.M., Kamholz, J. et al. (2012) Curcumin derivatives promoteSchwann cell differentiation and improve neuropathy in R98C CMT1B mice. Brain, 135, 3551-3566.
26. Murray, L.M., Comley, L.H., Thomson, D., Parkinson, N., Talbot, K. and Gillingwater, T.H. (2008) Selective vulnerability of motor neurons and dissociation of pre-and post-synaptic pathology at the neuromuscular junction in mouse models of spinal muscular atrophy. Hum. Mol. Genet., 17, 949-962.
27. Fischer, L.R., Culver, D.G., Tennant, P., Davis, A.A., Wang, M., Castellano-Sanchez, A., Khan, J., Polak, M.A. and Glass, J.D. (2004) Amyotrophic lateral sclerosis is a distal axonopathy: evidence in mice and man. Exp. Neurol., 185, 232-240.
28. Schmalbruch, H., Jensen, H.J., Bjaerg, M., Kamieniecka, Z. and Kurland, L. (1991) A new mouse mutant with progressive motor neuronopathy. J. Neuropathol. Exp. Neurol., 50, 192-204.
29. Miledi, R. and Slater, C.R. (1969) Electron-microscopic structure of denervated skeletal muscle. Proc. R. Soc. Lond. B Biol. Sci., 174, 253-269.
30. Miledi, R. and Slater, C.R. (1970) On the degeneration of rat neuromuscular junctions after nerve section. J. Physiol., 207, 507-528.
31. Winlow, W. and Usherwood, P.N. (1975) Ultrastructural studies of normal and degenerating mouse neuromuscular junctions. J. Neurocytol., 4, 377-394.
32. Valdez, G., Tapia, J.C., Kang, H., Clemenson, G.D. Jr, Gage, F.H., Lichtman, J.W. and Sanes, J.R. (2010) Attenuation of age-related changes in mouse neuromuscular synapses by caloric restriction and exercise. Proc. Natl. Acad. Sci. U S A, 107, 14863-14868.
33. Wokke, J.H., Jennekens, F.G., van den Oord, C.J., Veldman, H., Smit, L.M. and Leppink, G.J. (1990) Morphological changes in the human end plate with age. J. Neurol. Sci., 95, 291-310.
34. Oda, K. (1984) Age changes of motor innervation and acetylcholine receptor distribution on human skeletal muscle fibres. J. Neurol. Sci., 66, 327-338.
35. Cardasis, C.A. and LaFontaine, D.M. (1987) Aging rat neuromuscular junctions: a morphometric study of cholinesterase-stained whole mountsand ultrastructure. Muscle Nerve, 10, 200-213.
36. Thomson, S.R., Nahon, J.E., Mutsaers, C.A., Thomson, D., Hamilton, G., Parson, S.H. and Gillingwater, T.H. (2012) Morphological characteristics of motor neurons do not determine their relative susceptibility to degeneration in a mouse model of severe spinal muscular atrophy. PLoS One, 7, e52605.
37. Sanes, J.R. and Lichtman, J.W. (1999) Development of the vertebrate neuromuscular junction. Annu. Rev. Neurosci., 22, 389-442.
38. Brown, M.C., Jansen, J.K. and Van Essen, D. (1976) Polyneuronal innervation of skeletal muscle in new-born rats and its elimination during maturation. J. Physiol., 261, 387-422.
39. Tapia, J.C., Wylie, J.D., Kasthuri, N., Hayworth, K.J., Schalek, R., Berger, D.R., Guatimosim, C., Seung, H.S. and Lichtman, J.W. (2012) Pervasive synaptic branch removal in the mammalian neuromuscular system at birth. Neuron, 74, 816-829.
40. Marques, M.J., Conchello, J.A. and Lichtman, J.W. (2000) From plaque to pretzel: fold formation and acetylcholine receptor loss at the developing neuromuscular junction. J. Neurosci., 20, 3663-3675.
41. Mishina, M., Takai, T., Imoto, K., Noda, M., Takahashi, T., Numa, S., Methfessel, C. and Sakmann, B. (1986) Molecular distinction between fetal and adult forms of muscle acetylcholine receptor. Nature, 321, 406-411.
42. Gu, Y. and Hall, Z.W. (1988) Immunological evidence for a change in subunits of the acetylcholine receptor in developing and denervated rat muscle. Neuron, 1, 117-125.
43. Martinou, J.C. and Merlie, J.P. (1991) Nerve-dependent modulation of acetylcholine receptor ε-subunit gene expression. J. Neurosci., 11, 1291-1299.
44. Missias, A.C., Chu, G.C., Klocke, B.J., Sanes, J.R. and Merlie, J.P. (1996) Maturation of the acetylcholine receptor in skeletal muscle: regulation of the AChR γ-to-ε switch. Dev. Biol., 179, 223-238.
45. Yumoto, N., Wakatsuki, S. and Sehara-Fujisawa, A. (2005) The acetylcholine receptor γ-to-ε switch occurs in individual endplates. Biochem. Biophys. Res. Commun., 331, 1522-1527.
46. Fischbach, G.D. and Schuetze, S.M. (1980) A post-natal decrease in acetylcholine channel open time at rat end-plates. J. Physiol., 303, 125-137.
47. Sakmann, B. and Brenner, H.R. (1978) Change in synaptic channel gating during neuromuscular development. Nature, 276, 401-402.
48. 2+ homeostasis in nerve terminals of severe spinal muscular atrophy mice. J. Neurosci., 30, 849-857.
49. Sleigh, J.N., Gillingwater, T.H. and Talbot, K. (2011) The contribution of mouse models to understanding the pathogenesis of spinal muscular atrophy. Dis. Model. Mech., 4, 457-467.
50. Katsuno, M., Tanaka, F., Adachi, H., Banno, H., Suzuki, K., Watanabe, H. and Sobue, G. (2012) Pathogenesis and therapy of spinal and bulbar muscular atrophy (SBMA). Prog. Neurobiol., 99, 246-256.
51. Robberecht, W. and Philips, T. (2013) The changing scene of amyotrophic lateral sclerosis. Nat. Rev. Neurosci., 14, 248-264.
52. Messina, M.F., Messina, S., Gaeta, M., Rodolico, C., Salpietro Damiano, A.M., Lombardo, F., Crisafulli, G. and De Luca, F. (2012) Infantile spinal muscular atrophy with respiratory distress type I (SMARD 1): an atypical phenotype and review of the literature. Eur. J. Paediatr. Neurol., 16, 90-94.
53. Sleigh, J.N., Grice, S.J., Davies, K.E. and Talbot, K. (2013) Spinal muscular atrophy at the crossroads of basic science and therapy. Neuromuscul. Disord., 23, 96.
54. Gillingwater, T.H. and Ribchester, R.R. (2003) The relationship of neuromuscular synapse elimination to synaptic degeneration and pathology: insights from WldS and other mutant mice. J. Neurocytol., 32, 863-881.
55. Schaefer, A.M., Sanes, J.R. and Lichtman, J.W. (2005) A compensatory subpopulation of motor neurons in a mouse model of amyotrophic lateral sclerosis. J. Comp. Neurol., 490, 209-219.
56. Brown, M.C., Hopkins, W.G. and Keynes, R.J. (1982) Short-and long-term effects of paralysis on the motor innervation of two different neonatal mouse muscles. J. Physiol., 329, 439-450.
57. Evgenieva, E., Schweigert, P., Guntinas-Lichius, O., Pavlov, S., Grosheva, M., Angelova, S., Streppel, M., Irintchev, A., Skouras, E., Kuerten, S. et al. (2008) Manual stimulation of the suprahyoid-sublingual region diminishes polynnervation of themotor endplates and improves recovery of function after hypoglossal nerve injury in rats. Neurorehabil. Neural Repair, 22, 754-768.
58. Skouras, E., Ozsoy, U., Sarikcioglu, L. and Angelov, D.N. (2011) Intrinsic and therapeutic factors determining the recovery of motor function after peripheral nerve transection. Ann. Anat., 193, 286-303.
59. Benoit, P. and Changeux, J.P. (1975) Consequences of tenotomy on the evolution of multiinnervation in developing rat soleus muscle. Brain Res., 99, 354-358.
60. Thompson, W., Kuffler, D.P. and Jansen, J.K. (1979) The effect of prolonged, reversible block of nerve impulses on the elimination of polyneuronal innervation of new-born rat skeletal muscle fibers. Neuroscience, 4, 271-281.
61. Callaway, E.M., Soha, J.M. and Van Essen, D.C. (1987) Competition favouring inactive over active motor neurons during synapse elimination. Nature, 328, 422-426.
62. Ribchester, R.R. (1993) Co-existence and elimination of convergent motor nerve terminals in reinnervated and paralysed adult rat skeletal muscle. J. Physiol., 466, 421-441.
63. Kong, L., Wang, X., Choe, D.W., Polley, M., Burnett, B.G., Bosch-Marcé, M., Griffin, J.W., Rich, M.M. and Sumner, C.J. (2009) Impaired synaptic vesicle release and immaturity of neuromuscular junctions in spinal muscular atrophy mice. J. Neurosci., 29, 842-851.
64. Grosheva, M., Guntinas-Lichius, O., Angelova, S.K., Kuerten, S., Alvanou, A., Streppel, M., Skouras, E., Sinis, N., Pavlov, S. and Angelov, D.N. (2008) Local stabilization of microtubule assembly improves recovery of facial nerve function after repair. Exp. Neurol., 209, 131-144.
65. Stum, M., McLaughlin, H.M., Kleinbrink, E.L., Miers, K.E., Ackerman, S.L., Seburn, K.L., Antonellis, A. and Burgess, R.W. (2010) An assessment of mechanisms underlying peripheral axonal degeneration caused by aminoacyl-tRNA synthetase mutations. Mol. Cell. Neurosci., 46, 432-443.
66. Comley, L.H., Fuller, H.R., Wishart, T.M., Mutsaers, C.A., Thomson, D., Wright, A.K., Ribchester, R.R., Morris, G.E., Parson, S.H., Horsburgh, K. et al. (2011) ApoE isoform-specific regulation of regeneration in the peripheral nervous system. Hum. Mol. Genet., 20, 2406-2421.
67. Bogdanik, L.P., Sleigh, J.N., Tian, C., Samuels, M.E., Bedard, K., Seburn, K.L. and Burgess, R.W. (2013) Loss of the E3 ubiquitin ligase LRSAM1 sensitizes peripheral axons to degeneration in a mouse model of Charcot-Marie-Tooth disease. Dis. Model. Mech., 6, 780-792.
68. Sleigh, J.N., Barreiro-Iglesias, A., Oliver, P.L., Biba, A., Becker, T., Davies, K.E., Becker, C.G. and Talbot, K. (2014) Chondrolectin affects cell survival and neuronal outgrowth in in vitro and in vivo models of spinal muscular atrophy. Hum. Mol. Genet., 23, 855-869.